Channel Therapeutics Corporation (CHRO)
NYSEAMERICAN: CHRO · Real-Time Price · USD
0.9650
-0.0050 (-0.52%)
At close: May 28, 2025, 4:00 PM
0.9799
+0.0149 (1.54%)
After-hours: May 28, 2025, 4:42 PM EDT
Channel Therapeutics Market Cap
Channel Therapeutics has a market cap or net worth of $6.36 million as of May 28, 2025. Its market cap has decreased by -38.82% in one year.
Market Cap
6.36M
Enterprise Value
8.93M
1-Year Change
-38.82%
Ranking
Category
Stock Price
$0.97
Market Cap Chart
Since the IPO on February 16, 2024, Channel Therapeutics's market cap has decreased from $33.50M to $6.36M, a decrease of -81.00%. That is a compound annual growth rate of -72.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2025 | 6.40M | 65.58% |
| Dec 31, 2024 | 3.86M | -88.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 640.72B |
| Johnson & Johnson | 367.98B |
| AbbVie | 323.71B |
| Novo Nordisk | 298.78B |
| UnitedHealth Group | 268.12B |
| Abbott Laboratories | 228.44B |
| Novartis AG | 221.01B |
| AstraZeneca | 218.42B |